Search Results - "Mason, Kathryn"

Refine Results
  1. 1

    MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells by BRIDGES, Kathleen A, HIRAI, Hiroshi, BUSER, Carolyn A, BROOKS, Colin, HUIFENG LIU, BUCHHOLZ, Thomas A, MOLKENTINE, Jessica M, MASON, Kathryn A, MEYN, Raymond E

    Published in Clinical cancer research (01-09-2011)
    “…Radiotherapy is commonly used to treat a variety of solid tumors. However, improvements in the therapeutic ratio for several disease sites are sorely needed,…”
    Get full text
    Journal Article
  2. 2

    Investigating the Impact of a Musical Intervention on Preschool Children's Executive Function by Bowmer, Alice, Mason, Kathryn, Knight, Julian, Welch, Graham

    Published in Frontiers in psychology (20-12-2018)
    “…The impact of music interventions on the cognitive skills of young children has become the focus of a growing number of research studies in recent years. This…”
    Get full text
    Journal Article
  3. 3
  4. 4

    How Does Task Presentation Impact Motor Inhibition Performance in Young Children? by Mason, Kathryn, Bowmer, Alice, Welch, Graham F.

    Published in Frontiers in psychology (02-08-2021)
    “…Peg tapping tasks are commonly used as a measure of inhibitory skill in young children. However, differences in the way the task is presented may influence…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Tumor Induction in Mice After Localized Single- or Fractionated-Dose Irradiation: Differences in Tumor Histotype and Genetic Susceptibility Based on Dose Scheduling by Edmondson, Elijah F., DVM, Hunter, Nancy R., MS, Weil, Michael M., PhD, Mason, Kathryn A., MS

    “…Purpose To investigate differences in tumor histotype, incidence, latency, and strain susceptibility in mice exposed to single-dose or clinically relevant,…”
    Get full text
    Journal Article
  8. 8

    Cyclo-oxygenase-2 and its inhibition in cancer : Is there a role? by ZHONGXING LIAO, MASON, Kathryn A, MILAS, Luka

    Published in Drugs (New York, N.Y.) (01-01-2007)
    “…Despite recent improvements in chemotherapy and radiation therapy in cancer management with the addition of biological agents, novel treatment approaches are…”
    Get full text
    Journal Article
  9. 9

    Musical Activities, Prosocial Behaviors, and Executive Function Skills of Kindergarten Children by Ilari, Beatriz, Helfter, Susan, Huynh, Tina, Bowmer, Alice, Mason, Kathryn, Knight, Julian, Welch, Graham

    Published in Music & science (01-12-2021)
    “…Prosocial behaviors and executive function are staples of child development. Engagement in music has been associated with enhanced prosocial behaviors and…”
    Get full text
    Journal Article
  10. 10

    The Withers Archive: online availability of H. Rodney Withers' data by Thames, Howard D., Hunter, Nancy R., Mason, Kathryn A.

    Published in International journal of radiation biology (01-12-2016)
    “…We have collected lab notebooks from Rod Wither's many years of experimentation, from laboratories in Houston and Los Angeles, as well as from several of his…”
    Get full text
    Journal Article
  11. 11

    Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy by MASON, Kathryn A, ARIGA, Hisanori, NEAL, Robert, VALDECANAS, David, HUNTER, Nancy, KRIEG, Arthur M, WHISNANT, John K, MILAS, Luka

    Published in Clinical cancer research (01-01-2005)
    “…Synthetic oligodeoxynucleotides containing unmethylated CpG motifs detected by Toll-like receptor 9 of dendritic cells and B cells have potent immunomodulatory…”
    Get full text
    Journal Article
  12. 12

    130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain by WIEDENMANN, Nicole, VALDECANAS, David, HUNTER, Nancy, HYDE, Stephen, BUCHHOLZ, Thomas A, MILAS, Luka, MASON, Kathryn A

    Published in Clinical cancer research (15-03-2007)
    “…Purpose: 130-nm albumin–bound paclitaxel (nab-paclitaxel) is a novel solvent-free albumin-bound paclitaxel, designed to avoid solvent-related toxicity…”
    Get full text
    Journal Article
  13. 13

    CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors by Mason, Kathryn A., Neal, Robert, Hunter, Nancy, Ariga, Hisanori, Ang, Kian, Milas, Luka

    Published in Radiotherapy and oncology (01-08-2006)
    “…Synthetic oligodeoxynucleotides (ODNs) containing unmethylated cytosine-guanine (CpG) motifs bind to Toll-like receptor 9 (TLR9) and stimulate both innate and…”
    Get full text
    Journal Article
  14. 14

    The Impact of Timing of EGFR and IGF-1R Inhibition for Sensitizing Head and Neck Cancer to Radiation by MATSUMOTO, Fumihiko, VALDECANAS, David N, MASON, Kathryn A, MILAS, Luka, ANG, K. Kian, RAJU, Uma

    Published in Anticancer research (01-08-2012)
    “…Targeting the epidermal growth factor receptor (EGFR) improved radiotherapy outcome by 10-15% in head and neck tumors (HNSCC). We tested the therapeutic…”
    Get full text
    Journal Article
  15. 15

    INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin by Mason, Kathryn A., Valdecanas, David, Hunter, Nancy R., Milas, Luka

    Published in Investigational new drugs (01-02-2008)
    “…Summary Poly(ADP-ribose) synthetase inhibitor, INO-1001, is known to sensitize cells to radiation in vitro by inhibiting the repair of DNA damage. Recent…”
    Get full text
    Journal Article
  16. 16

    CpG oligodeoxynucleotide enhances tumor response to radiation by MILAS, Luka, MASON, Kathryn A, ARIGA, Hisanori, HUNTER, Nancy, NEAL, Robert, VALDECANAS, David, KRIEG, Arthur M, WHISNANT, John K

    Published in Cancer research (Chicago, Ill.) (01-08-2004)
    “…CpG oligodeoxynucleotides (ODNs) are synthetic DNA sequences containing unmethylated cytosine-guanine motifs with potent immunomodulatory effects. Via…”
    Get full text
    Journal Article
  17. 17

    Inhibition of P-TEFb by DRB suppresses SIRT1/CK2α pathway and enhances radiosensitivity of human cancer cells by Wang, Zhi-Qiang, Johnson, Casey L, Kumar, Amit, Molkentine, David P, Molkentine, Jessica M, Rabin, Tatiana, Mason, Kathryn A, Milas, Luka, Raju, Uma

    Published in Anticancer research (01-12-2014)
    “…Positive transcription elongation factor-b (P-TEFb) is a complex containing CDK9 and a cyclin (T1, T2 or K). The effect of inhibition of P-TEFb by…”
    Get full text
    Journal Article
  18. 18

    Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors by Nakata, Eiko, Mason, Kathryn A, Hunter, Nancy, Husain, Amir, Raju, Uma, Liao, Zhongxing, Ang, Kian K, Milas, Luka

    “…Cyclooxygenase-2 (COX-2) is an enzyme expressed primarily in pathologic states, such as inflammatory disorders and cancer, where it mediates prostaglandin…”
    Get more information
    Journal Article
  19. 19

    Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment by MASON, Kathryn A, RAJU, Uma, BUCHHOLZ, Thomas A, LI WANG, MILAS, Zvonimir L, MILAS, Luka

    Published in American journal of clinical oncology (01-02-2014)
    “…Recent research on inhibitors of poly (ADP-ribose) polymerase (PARP) has demonstrated their potential for improving cancer therapy. They inhibit protein poly…”
    Get full text
    Journal Article
  20. 20

    Preclinical Biologic Assessment of Proton Beam Relative Biologic Effectiveness at Proton Therapy Center Houston by Mason, Kathryn A., M.S, Gillin, Michael T., Ph.D, Mohan, Radhe, Ph.D, Cox, James D., M.D

    “…The clinical use of protons for the treatment of cancer is one of the most technologically advanced forms of therapy. The newly commissioned M.D. Anderson…”
    Get full text
    Journal Article